NCT04646681 (Patient Portal) is a NA clinical trial of ConnectCare in Depression, sponsored by Carolyn L Turvey.

Who is sponsoring NCT04646681?

NCT04646681 is sponsored by Carolyn L Turvey.

What drugs are being tested in NCT04646681?

Interventions in NCT04646681: ConnectCare.

What condition does NCT04646681 study?

NCT04646681 studies Depression.

Is NCT04646681 still recruiting?

NCT04646681 is currently completed. Last updated 10 June 2022.

Last reviewed 2022-06-10 · How we verify

NCT04646681: Patient Portal

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes

Completed NA Last updated 10 June 2022

What this trial tests

NA trial testing ConnectCare in Depression in 30 participants. Completed in 30 April 2022.

Timeline

31 March 2021

Primary endpoint
30 April 2022

30 April 2022

Quick facts

Lead sponsor	Carolyn L Turvey
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	30
Start date	31 March 2021
Primary completion	30 April 2022
Estimated completion	30 April 2022
Sites	1 location across United States

Drugs / interventions tested

ConnectCare

Conditions studied

Depression — all drugs for Depression →

Sponsor

Carolyn L Turvey

Who can join

Adults 18 to 89, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to learn how best to use patient portals to help improve the treatment of mood disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04646681 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carolyn L Turvey
Last refreshed: 10 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04646681.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing